COMMENTARY: BRCA1 2 Mutations, Vulnerability to Breast Ovarian Cancer, and Current and Future Treatment Modalities. J. Can. Res. Updates 2016, 5 (2),  45-46. https://doi.org/10.6000/1929-2279.2016.05.02.1.